CDK4/6 inhibitors in breast cancer: spotting the difference

Affiliations

• 1 Oncology Department, International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.
• 2 Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
• 3 Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.
• 4 Oncology Department, International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain. jacortes@vhio.net.
• 5 Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. jacortes@vhio.net.
• 6 Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. jacortes@vhio.net.
• 7 Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. jacortes@vhio.net.
• 8 Breast Cancer Research program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. jacortes@vhio.net.
• 9 Oncology Department, Arnau de Vilanova University Hospital, Valencia, Spain.